Section-like container element for one or more notes that are not part of the narrative flow (for example, note added in proof, dedication).
Such notes are typically material outside the regular technical content of the document, extra material added by a contributor or by the publisher during or after the regular text has been processed, a note by the editor, or a note added after print publication.
There is no predefined list of types for the @notes-type attribute, but values publishers have used include “added-in-proof”, “dedication”, “conflict-of-interest”, “death-notice”, “editor-note”, “added-post-print”, “added-post-electronic-publication”, and “translator-note”.
A typical end-of-document note is a “Note in Proof”. A Note in Proof contains late-breaking news items or other material produced while the document was being typeset or was otherwise in production, that therefore happened too late to be included in the text of the work. This is typically NOT peer-reviewed content, and citations to other material within such content are usually integrated into the text or put inside the last paragraph, not listed separately in a bibliographic reference list <ref-list>.
The possibility of prepublication online as well as slightly differing content in the online versus print version of the same work has led to an increase in notes that are “only for the print” or “only for web” versions. The @specific-use attribute may be used to mark a note as belonging to only a specific format, such as “print-only”.
<!ELEMENT notes %notes-model; >
Expanded Content Model
(sec-meta?, label?, title?, (address | alternatives | array | boxed-text | chem-struct-wrap | code | fig | fig-group | graphic | media | preformat | supplementary-material | table-wrap | table-wrap-group | disp-formula | disp-formula-group | def-list | list | tex-math | mml:math | p | related-article | related-object | ack | disp-quote | speech | statement | verse-group | x)*, (sec)*, (notes | fn-group | glossary | ref-list)*)
The following, in order:
- <sec-meta> Section Metadata, zero or one
- <label> Label (of an Equation, Figure, Reference, etc.), zero or one
- <title> Title, zero or one
- Any combination of:
- Paragraph-level Display Elements
- <address> Address/Contact Information
- <array> Array (Simple Tabulation)
- <boxed-text> Boxed Text
- <chem-struct-wrap> Chemical Structure Wrapper
- <code> Code
- <fig> Figure
- <fig-group> Figure Group
- <graphic> Graphic
- <media> Media Object
- <preformat> Preformatted Text
- <supplementary-material> Supplementary Material Metadata
- <table-wrap> Table Wrapper
- <table-wrap-group> Table Wrapper Group
- <alternatives> Alternatives For Processing
- <disp-formula> Formula, Display
- <disp-formula-group> Formula, Display Group
- Math Elements
- <p> Paragraph
- Related Material Elements
- <ack> Acknowledgments
- <disp-quote> Quote, Displayed
- <speech> Speech
- <statement> Statement, Formal
- <verse-group> Verse Form for Poetry
- <x> X - Generated Text and Punctuation
- Paragraph-level Display Elements
- <sec> Section, zero or more
- Any combination of:
This element may be contained in:
... <back> <glossary>...</glossary> <notes> <sec><title>Note Added in Proof</title> <p>Similar sequence information has been obtained in another study (S. Mishiro, personal communication) and has been deposited under GenBank accession numbers –. For the purposes of HBV nomenclature, we have proposed that the chimpanzee HBV be abbreviated as ChHBV.</p> </sec> </notes> <ref-list>...</ref-list> ...</back> ...
... <front>... <article-meta>...</article-meta> <notes notes-type="disclaimer"> <p><italic>The information and/or opinions expressed in this Guest Editorial are those of the author(s). They are neither endorsed nor disputed by <roman>Prescribing Physician</roman> or the Pharma-Physician Coalition. Questions about or comments on this editorial’s content should be directed to the corresponding author.</italic></p> </notes> </front> ...
... <front>... <article-meta>...</article-meta> <notes notes-type="dedication"> <p>We dedicate this paper to our professor, Dr. Robert Jemmings, whose critique of the underlying study identified potential bias in the analysis and strengthened our argument.</p> </notes> </front> ...
... <front>... <article-meta>...</article-meta> <notes notes-type="editor-note"> <p><sc>EDITOR’S NOTE:</sc> The study examined in this article was neither blinded nor placebo-controlled. More recent studies suggest that traditional medications when compared with placebos do decrease symptoms of this condition. Further research is needed to ascertain the efficacy of such medications; until research is conducted, traditional medications may be an effectual treatment.</p> </notes> </front> ...
Post publication information:
... <front>... <article-meta>...</article-meta> <notes notes-type="after-epub"> <p>After publication, the authors discovered an error in the text concerning the administration of the medication levothyroxine. The text reads: “Individuals prescribed the thyroid hormone, levothyroxine, should eat within thirty minutes of taking the medication.” The text should read: “Individuals prescribed the thyroid hormone, levothyroxine, should <italic>not</italic> eat within thirty minutes of taking the medication.”</p> </notes> </front> ...
Conflict of interest information:
... <front>... <article-meta>...</article-meta> <notes notes-type="conflict-interest"> <p><bold>Competing interests:</bold> RM reports that he is employed by an academic medical center that has both intellectual property and performs clinical trials. DK declares that he has no competing interests.</p> </notes> </front> ...